Pediatric Cardiology

Top Story

NLA: Lp(a) can help assess ASCVD risk in several patient populations

May 17, 2019
FDA News

FDA approves Fragmin, first anticoagulant for children

May 16, 2019
The FDA today approved dalteparin sodium injection to reduce the recurrence of symptomatic venous thromboembolism among children aged at least 1 month. Children with VTE…
FDA News

FDA grants clearance for steerable introducer for transseptal access

May 10, 2019
BioCardia announced it has received FDA clearance for a steerable introducer used for transseptal access to the heart. The steerable introducer (AVANCE) is virtually…

Esports’ explosive growth prompts warnings, tips for clinicians

May 6, 2019
Esports — “competitive gaming at a professional level,” according to Newzoo, an organization that monitors the industry — is poised to become one…
More Headlines »

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

This activity is supported by an unrestricted educational grant from Amarin Pharma, Inc.

Despite therapeutic advances, cardiovascular disease (CVD) continues to be the leading cause of preventable death in…
More »
Meeting News

VIDEO: Factors linked with cardiac dysfunction in children with neonatal lupus

November 10, 2017
More »